Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Chastain

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Therapeutic Advances in Infectious Disease|September 4, 2023
Hospitalization risk among patients with Mpox infection-a propensity score matched analysisAndrés F Henao-Martínez, Chloe M Orkin, Boghuma K Titanji, et al.
Mycoses|February 24, 2026
Epidemiology and Outcomes of Sporotrichosis: A Descriptive Real-World Analysis From a Global CohortSamantha Schapiro, Nicholas Pulciano, Julian Galindo-Ramirez, et al.
International Journal of Antimicrobial Agents|May 9, 2023
Dalbavancin vs standard of care for Staphylococcus aureus bacteraemia in patients unable to receive outpatient parenteral antimicrobial therapyJ Dillon Frazier, Laura Leigh Stoudenmire, Jamie L Wagner, et al.
Contemporary Clinical Trials|November 11, 2022
Distribution of age, sex, race, and ethnicity in COVID-19 clinical drug trials in the United States: A reviewDaniel B Chastain, Vishwa S Patel, Alexandria M Jefferson, et al.
Journal of Primary Care & Community Health|April 15, 2022
Clinical Severity on Hospital Admission for COVID-19: An Analysis of Social Determinants of Health From an Early Hot Spot in the Southeastern U.SDaniel B Chastain, Sharmon P Osae, Geren M Thomas, et al.
Open Forum Infectious Diseases|June 18, 2024
Risk of Invasive Fungal Infections in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors: A Case-Control Propensity Score-Matched AnalysisNelson Iván Agudelo Higuita, Daniel B Chastain, Brian Scott, et al.
European Journal of Pharmacology|November 6, 2023
A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitisAbdulaziz H Alanazi, Daniel B Chastain, Madhuri Rudraraju, et al.
Current Microbiology|November 1, 2023
Diabetes Mellitus Type 2 as a Risk Factor and Outcome Modifier for Cryptococcosis in HIV Negative, Non-transplant Patients, a Propensity Score Match AnalysisVanessa M Kung, Carolina Ferraz, Matthew Kennis, et al.
Therapeutic Advances in Infectious Disease|October 24, 2022
Seasonal variations and risk factors of <i>Streptococcus pyogenes</i> infection: a multicenter research network studyMatthew Kennis, Alex Tagawa, Vanessa M Kung, et al.
Mycoses|March 1, 2024
Glucocorticoids as a risk factor for infection and adverse outcomes in non-HIV and non-transplant patients with cryptococcal meningitisLuke Kim, Carolina Ferraz, Michaele Francesco Corbisiero, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Therapeutic Advances in Infectious Disease|September 4, 2023
Hospitalization risk among patients with Mpox infection-a propensity score matched analysisAndrés F Henao-Martínez, Chloe M Orkin, Boghuma K Titanji, et al.
Mycoses|February 24, 2026
Epidemiology and Outcomes of Sporotrichosis: A Descriptive Real-World Analysis From a Global CohortSamantha Schapiro, Nicholas Pulciano, Julian Galindo-Ramirez, et al.
International Journal of Antimicrobial Agents|May 9, 2023
Dalbavancin vs standard of care for Staphylococcus aureus bacteraemia in patients unable to receive outpatient parenteral antimicrobial therapyJ Dillon Frazier, Laura Leigh Stoudenmire, Jamie L Wagner, et al.
Contemporary Clinical Trials|November 11, 2022
Distribution of age, sex, race, and ethnicity in COVID-19 clinical drug trials in the United States: A reviewDaniel B Chastain, Vishwa S Patel, Alexandria M Jefferson, et al.
Journal of Primary Care & Community Health|April 15, 2022
Clinical Severity on Hospital Admission for COVID-19: An Analysis of Social Determinants of Health From an Early Hot Spot in the Southeastern U.SDaniel B Chastain, Sharmon P Osae, Geren M Thomas, et al.
Open Forum Infectious Diseases|June 18, 2024
Risk of Invasive Fungal Infections in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors: A Case-Control Propensity Score-Matched AnalysisNelson Iván Agudelo Higuita, Daniel B Chastain, Brian Scott, et al.
European Journal of Pharmacology|November 6, 2023
A multi-arm, parallel, preclinical study investigating the potential benefits of acetazolamide, candesartan, and triciribine in combination with fluconazole for the treatment of cryptococcal meningoencephalitisAbdulaziz H Alanazi, Daniel B Chastain, Madhuri Rudraraju, et al.
Current Microbiology|November 1, 2023
Diabetes Mellitus Type 2 as a Risk Factor and Outcome Modifier for Cryptococcosis in HIV Negative, Non-transplant Patients, a Propensity Score Match AnalysisVanessa M Kung, Carolina Ferraz, Matthew Kennis, et al.
Therapeutic Advances in Infectious Disease|October 24, 2022
Seasonal variations and risk factors of <i>Streptococcus pyogenes</i> infection: a multicenter research network studyMatthew Kennis, Alex Tagawa, Vanessa M Kung, et al.
Mycoses|March 1, 2024
Glucocorticoids as a risk factor for infection and adverse outcomes in non-HIV and non-transplant patients with cryptococcal meningitisLuke Kim, Carolina Ferraz, Michaele Francesco Corbisiero, et al.
Pageof 12